Photocure ASA - Presentation of a new commercial strategy for Hexvix®

Dokument -

Photocure ASA - Presentation of a new commercial strategy for Hexvix®

Photocure, the Norwegian specialty pharmaceutical company focused in dermatology and cancer, is pleased to invite to a presentation on Tuesday 27 September 2011 to further execution of a new commercial strategy for Hexvix in partnership with Ipsen, a global specialty-driven biopharmaceutical company.
go to media item
Lisens:
Bruk i media
Innholdet kan lastes ned, bli brukt og delt i ulike medier av for eksempel journalister, bloggere, spaltister, kommentatorer etc., med den hensikt å formidle, fortelle og kommentere dine pressemeldinger, oppslag eller informasjon, forutsatt at innholdet er uendret og brukt i sin helhet. Opphaver skal navngis i den grad og på den måten god skikk tilsier (dette betyr f.eks. at fotografer nesten alltid skal navngis).
Filformat:
.pdf
Last ned

Kontakter

Relatert innhold

  • Photocure ASA - Presentation of a new commercial strategy for Hexvix®

    Photocure, the Norwegian specialty pharmaceutical company focused in dermatology and cancer, is pleased to invite to a presentation on Tuesday 27 September 2011 to further execution of a new commercial strategy for Hexvix in partnership with Ipsen, a global specialty-driven biopharmaceutical company.